SC
Scilex Holding Company
SCLX · NASDAQ
$4.06 -7.94% (-$0.35)
1M -25.09%
Market Cap $37.4M
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$4.88
20.2% upside
Current Price
$4.06
Undervalued Fair Value Overvalued
According to Bulios Fair Price, SCLX is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Weak
2/9Valuation
100 /100
Cheap P/S 1.18x
P/FCF N/A
P/B N/A
Growth
0 /100
Declining Rev. growth 7.35%
FCF growth N/A
Book val. growth N/A
Profitability
20 /100
Weak FCF margin 56.69%
Op. margin 903.52%
Gross margin 50.47%
Quality
59 /100
Average ROA 176.82%
Asset turnover 0.12x
ROIC 162.61%
Debt
0 /100
High Int. coverage -20.98x
Current ratio 0.07x
Net debt/EBITDA N/A
Stability
6 /100
Unstable Profitable years 0
EPS volatility 365.69%
Beta 1.72x
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about SCLX
Online
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Henry H. Ji
Employees
34
Headquarters
Palo Alto
Upcoming events
02 DEC
Earnings
Upcoming earnings report